Sitemap

Posts

Isolation and profiling of single circulating tumor cells in myeloma: a new workflow for liquid biopsies.
PSCC Innovation Forum 2026 – Paris Saclay Cancer Cluster
Stand Up To Cancer (SU2C) Scientific Summit 2026
Analysis of Circulating Tumor Cells (CTCs) in Patients with Metastatic Melanoma Before and During Systemic Treatment
🧫 Can we isolate viable #ctcs for downstream applications? Emile Lakis answers your question #2 ! 🔬
ScreenCell Will Standardize Its CTC Isolation Kit Range in 2026
ISLB 2025 : ScreenCell® at the 7th Annual Liquid Biopsy Conference in Orlando
ScreenCell® to attend ESLB 2025 General Assembly in Madrid
🎥 Q&A: Emile Lakis answers your question! #1 👩‍🔬
Learn in depth how our CTCs isolation support #cancerresearch
Meet ScreenCell® at the ACTC 2025 (7th Advances in Circulating Tumor Cells Meeting)
Liquid biopsy in breast cancer: Redefining precision medicine
CTC Analysis: a new workflow combining ScreenCell Technology with Stilla Crystal Digital PCR®
Optimizing Detection of Circulating Tumor Cells in Breast Cancer: Unveiling New Markers for Clinical Applications
2nd IBC-IC in Africa: Discover the Power of ScreenCell® Technology
ISMRC 2025: Join ScreenCell to Discover Our CTC Isolation Method
ScreenCell at SIMEM 2025: Meet us on the Genethical® stand
Circulating Tumor Cells from Surgical Manipulation Predict Recurrence and Poor Prognosis in Non-Small Cell Lung Cancer
What is a Circulating Tumor Cell (CTC)? Definition, Detection and Cancer Research
🔬 CTCs in clinical routine: what concrete applications? Our CSO answers your question
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device (PROBE-CTC)
ScreenCell joins PMT Santé in Besançon
Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial
Is ScreenCell’s technology sensitive enough to detect small amounts of Circulating Tumor Cells ?
Can we perform mutational studies on CTCs enriched by ScreenCell technology?
ScreenCell joins the European Liquid Biopsy Society (ELBS)
Fast and efficient isolation of murine circulating tumor cells using screencell technology for pre-clinical analyzes
An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer
What role will the analysis of Circulating Tumor Cells (CTCs) play in 2024 ?
Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas
Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus – Cytomorphological Heterogeneity
Cytomorphologic visualization of circulating tumor cells in urinary bladder cancer patients using ScreenCell™ technology: Potential as a simple cytology test
Ex vivo expansion of circulating tumour cells (CTCs)
Evaluation of Circulating Tumor Cells (CTCs) by the ScreenCell® device in breast cancer: validation of biomarkers
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.
The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer
Thoracic surgery in the UK
Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer
Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients
Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21).
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
Y disruption, autosomal hypomethylation and poor male lung cancer survival.
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer
Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma
Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques
Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients
Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level
Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations
Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis
Cluster circulating tumor cells in surgical cases of lung cancer
A Novel Combined Methodology for Isolation and Detection of Circulating Tumor Cells based on Flow Cytometry and Cellular Filtration Technologies
Lack of association between Screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical study.
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment
Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization.
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma.
Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer: 18F-FDG PET/CT Study
EpCAM-expressing circulating tumor cells in colorectal cancer
Détection des mutations RAS dans les cellules tumorales circulantes : applications au cancer colorectal et perspectives
Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
Perioperative detection of circulating tumour cells in patients with lung cancer.
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
Cytologic Characteristics of Circulating Epithelioid Cells in Pancreatic Disease
Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups
Lung cancer biopsy dislodges tumor cells into circulating blood.
Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
Impact of label-free technologies in head and neck cancer circulating tumour cells
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology (EXPEVIVO-CTC)
KRAS mutations in pancreatic circulating tumor cells: a pilot study
Circulating tumor cells (CTCs) HER2 expression in breast cancer using ScreenCelltechnology, a rapid and save method of CTC selection based on size
Detection and Characterization of CTCs Isolated by ScreenCell® Size Exclusion Technology in Metastatic Breast Cancer
Did circulating tumor cells tell us all they could? The missed circulating tumor cell message in breast cancer
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings
Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC
Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy
Circulating Tumour Cells in Patients with Malignant Lung Tumors Undergoing Radio-frequency Ablation
Circulating tumor cells found in patients with localized and advanced pancreatic cancer
Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis
Researchers use ScreenCell® to enrich Breast Cancer CTC Biomarkers
Researchers report ScreenCell® usage for Colorectal Cancer – CTC Biomarker
ScreenCell® Marks Shipment of 50,000 units for Characterization of CirculatingTumor Cells
Colorectal carcinomas in 2013: the search for powerful prognostic markers is still on the go!
Three-Dimensional Telomeric Analysis of Isolated Circulating Tumor Cells (CTCs) Defines CTC Subpopulations
Rapid separation of mononuclear hodgkin from multinuclear reed-sternberg cells
Evaluation de la technique ScreenCell pour l’isolement et la caractérisation des cellules tumorales circulantesdans le cancer du colon
Ex-vivo expansion of CTCs in culture isolated by sizefrom patients with melanoma
Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study
Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis.
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
The Capture of Pancreatic CTC for Cytological, Molecular and Cell Culture Evaluation.
Rapid and Simple Isolation of Circulating Tumor Cells for Clinical and Research Applications Using ScreenCell ®
A new device for rapid isolation by size and characterization of rare circulating tumor cells

Scientific resources

About ScreenCell

Sitemap

Pages

Categories

Posts

About

Technology

Resources

Contact